CGON US Equity

CG Oncology, Inc.

Health Care · Biological Products, (No Diagnostic Substances) · CIK 1991792 · FY ends Dec 31

$80.68

+4.39 (+5.75%)

USD · as of 2026-08-19 · marketstack

Switch Ticker

Documents

3 of 3 10-Ks readable here

Period end	Filed	Form	Read here	EDGAR
2025-12-31	2026-02-27	10-K	read · risk factors · MD&A	index · original · 0001193125-26-079498
2024-12-31	2025-03-28	10-K	read · risk factors · MD&A	index · original · 0000950170-25-046351
2023-12-31	2024-03-26	10-K	read · risk factors · MD&A	index · original · 0000950170-24-036143

69 captions · 3 filings

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

69 captions across 3 filings4 added9 dropped56 in every year3 of 3 10-Ks on file are cached here

Risk-factor caption

2023

2024

2025

Years

●

2 rw

●

3 rw

●

The filer's own 10-K text · 3 filings read

Rows are the filing's own headings, verbatim — nothing is summarized or generated.

A blank cell means the filer did not print that heading that year — not that the risk ended.

Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.

3 filings measured

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

Filed	Period end	Document words	Item 1A words	Negation / 10k	Hedging / 10k	Filing
2024-03-26	2023-12-31	99,199	42,226	68.55	183.57	read · EDGAR ↗
2025-03-28	2024-12-31	85,946	43,001	74.47	209.32	read · EDGAR ↗
2026-02-27	2025-12-31	89,660	43,442	72.61	211.47	read · EDGAR ↗

The filer's own 10-K text · 3 filings measured

House wordlists, not a licensed dictionary and not tuned against returns.

9 negation words · 40 hedging words — hover to read both lists.

Each point sits at its filing date and is held flat until the next filing.